ArticleInfection and drug resistance2025
Analysis of Clinical Characteristics and the Effect of Symptomatic Supportive Treatment for Severe Neonatal Enterovirus Infection.
Article in Infection and drug resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Invasive Neonatal Enterovirus Infection: A Case Series and Review of the Literature.Children (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To retrospectively analyze cases of neonatal enterovirus (EV) infection, identify risk factors for severe infection, pathological characteristics, and prognostic differences, and provide a basis for early identification of high-risk neonates. Methods: Neonates diagnosed with EV infection and admitted to Zhuzhou Central Hospital between January 2020 and December 2023 were included in the study. Based on disease severity, they were divided into a mild infection group (n = 149) and a severe infection group (n = 44). Data on demographic characteristics, clinical manifestations, laboratory findings, treatment methods, and prognosis were collected and statistically analyzed using SPSS 26.0. Results: Compared to the mild infection group, the severe infection group had lower gestational age (36.61 vs 38.50 weeks, P < 0.001) and higher preterm birth rates (P < 0.05). They presented earlier with higher incidences of rash, respiratory symptoms, and sepsis-like signs (all P < 0.05). Severe cases had significantly higher rates of pneumonia, myocarditis, necrotizing hepatitis, and DIC (all P < 0.001), with a mortality rate of 54.55% (P < 0.001). Laboratory findings showed more thrombocytopenia, coagulation dysfunction, and organ injury markers in the severe group (all P < 0.001). Mild cases required mainly non-invasive treatment, while severe cases had high mortality despite intensive interventions. Among survivors, 50% required long-term neurological rehabilitation. Conclusion: Severe neonatal EV infection is closely associated with preterm birth and perinatal infection, characterized by thrombocytopenia, coagulation dysfunction, and multiple organ damage. Early monitoring of high-risk neonates, especially preterm infants, should be reinforced. For neonates presenting within the first seven days of life with rash or respiratory distress accompanied by a rapid decline in platelet count, intensive care should be promptly initiated. Further research is needed to explore targeted antiviral therapies and immune modulation strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.